Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Accumulated Expenses: 2018-2019

Historic Accumulated Expenses for DiaMedica Therapeutics (DMAC) over the last 1 years, with Sep 2019 value amounting to $837,000.

  • DiaMedica Therapeutics' Accumulated Expenses was N/A to $837,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $837,000, marking a year-over-year change of. This contributed to the annual value of $808,000 for FY2018, which is N/A change from last year.
  • As of Q3 2019, DiaMedica Therapeutics' Accumulated Expenses stood at $837,000, which was up 32.86% from $630,000 recorded in Q2 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Accumulated Expenses peaked at $837,000 during Q3 2019, and registered a low of $630,000 during Q2 2019.
  • In the last 2 years, DiaMedica Therapeutics' Accumulated Expenses had a median value of $747,000 in 2018 and averaged $740,250.